Less noise. More signal.
01
Every board in life sciences is asked the same question. Who is accountable for the AI outcome. The role most boards will appoint does not yet exist at scale.
02
The white space is the room that holds the conversation differently. Closed-door. By invitation. Early. A circle for the leaders preparing for the role before the queue forms.
03
the Circle. AIO is that room. Senior leadership preparing for AI accountability convened across drug discovery, R&D, manufacturing and supply. Less noise. More signal.
04
In the Circle. Faculty drawn from the leaders already carrying the responsibility · with or without the title. Announced in cadence with the programme.
The role that does not yet exist at scale.
The gap.
Technology moves faster than leadership. Boards know they will appoint the role · few yet have the candidate. Models without governance · drift. Pilots without accountability · stall. The line between AI ambition and AI outcome is the officer who carries both.
The Circle.
AIO Circle convenes the leaders preparing for that role · across drug discovery, R&D, manufacturing and supply. The corridor where AI ambition becomes clinical outcome · or breaks. The Circle closes the gap.
The decision.
Who decides. What governs. Who is accountable. Three questions the room must hold before the queue forms. For the leaders shaping what comes next.
"The Circle within the Circle. Where the role is shaped before it is named."
Uwe Gottschalk · Former CSO Lonza · Operating Partner, Keensight Capital
By invitation. By relevance. By room.
Attend AIO Circle 2027